McKesson Corporation $MCK Shares Sold by Unique Wealth LLC

Unique Wealth LLC decreased its position in shares of McKesson Corporation (NYSE:MCK) by 25.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,939 shares of the company’s stock after selling 1,014 shares during the quarter. Unique Wealth LLC’s holdings in McKesson were worth $2,411,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of MCK. GGM Financials LLC acquired a new position in McKesson during the third quarter worth $25,000. State of Wyoming acquired a new stake in McKesson in the second quarter valued at $29,000. Hopwood Financial Services Inc. acquired a new stake in McKesson in the third quarter valued at $31,000. Board of the Pension Protection Fund purchased a new position in shares of McKesson in the fourth quarter valued at $33,000. Finally, Vermillion & White Wealth Management Group LLC acquired a new position in shares of McKesson during the 3rd quarter worth $33,000. Institutional investors and hedge funds own 85.07% of the company’s stock.

McKesson Stock Down 2.3%

MCK stock opened at $898.82 on Friday. The company has a market cap of $110.10 billion, a price-to-earnings ratio of 25.85, a PEG ratio of 1.48 and a beta of 0.38. The business has a fifty day simple moving average of $902.24 and a 200-day simple moving average of $831.10. McKesson Corporation has a 52 week low of $637.00 and a 52 week high of $999.00.

McKesson (NYSE:MCK) last issued its earnings results on Wednesday, February 4th. The company reported $9.34 earnings per share for the quarter, beating analysts’ consensus estimates of $9.19 by $0.15. The firm had revenue of $106.16 billion for the quarter, compared to analysts’ expectations of $105.98 billion. McKesson had a negative return on equity of 338.97% and a net margin of 1.09%.The firm’s revenue for the quarter was up 11.4% compared to the same quarter last year. During the same quarter last year, the firm earned $8.03 earnings per share. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. As a group, analysts expect that McKesson Corporation will post 32.77 earnings per share for the current fiscal year.

McKesson Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, April 1st. Stockholders of record on Monday, March 2nd will be issued a dividend of $0.82 per share. The ex-dividend date is Monday, March 2nd. This represents a $3.28 dividend on an annualized basis and a dividend yield of 0.4%. McKesson’s payout ratio is presently 9.43%.

Insider Activity

In related news, EVP Leann B. Smith sold 190 shares of the firm’s stock in a transaction that occurred on Tuesday, February 17th. The shares were sold at an average price of $945.00, for a total value of $179,550.00. Following the transaction, the executive vice president owned 2,989 shares in the company, valued at approximately $2,824,605. This trade represents a 5.98% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CAO Napoleon B. Rutledge, Jr. sold 328 shares of McKesson stock in a transaction that occurred on Friday, February 6th. The shares were sold at an average price of $955.00, for a total transaction of $313,240.00. The SEC filing for this sale provides additional information. In the last 90 days, insiders have sold 3,868 shares of company stock worth $3,743,820. Insiders own 0.08% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on the stock. Zacks Research lowered shares of McKesson from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, November 25th. Wells Fargo & Company raised their target price on shares of McKesson from $914.00 to $925.00 and gave the company an “equal weight” rating in a report on Thursday, February 5th. Morgan Stanley reaffirmed an “overweight” rating and issued a $966.00 price target on shares of McKesson in a report on Thursday, January 29th. Robert W. Baird set a $968.00 price objective on McKesson in a research note on Wednesday, January 14th. Finally, Mizuho boosted their price objective on shares of McKesson from $880.00 to $885.00 and gave the company a “neutral” rating in a research report on Thursday, February 5th. Thirteen equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. Based on data from MarketBeat, McKesson has an average rating of “Moderate Buy” and a consensus target price of $960.93.

McKesson Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.